Login
Navigate Fool.com
Will CYCC beat
the market?
Community Rating: 2 Stars: Unattractive

3.04 0.04 (1.33%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.05
Previous Close $3.00
Daily Range $2.99 - $3.07
52-Week Range $2.73 - $8.18
Market Cap $33.1M
P/E Ratio -1.18
Dividend (Yield) $0.00 (0.0%)
Volume 828,653
Average Daily Volume 205,688
Current FY EPS $0.00

How do you think CYCC
will perform against the market?

Top CYCC Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted July 2, 2011

With the dilutive financing today, all the pieces are in place for Cyclacel to rebound in the second half: 1. Bad news out of the way. Selciclib failed in the APPRAISE trial and will no longer weigh … More

2 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted May 10, 2011

Cyclacel is carving out a new spike this month, undoubtedly related to ASCO's approach. But the company's presentations are unlikely to contain meaningful new data - the SEAMLESS phase III trial of sa … More

0 Replies Reply Report this Post

News & Commentary

Cyclacel Announces New Stock Issue

The pharmaceutical company hopes to reap gross proceeds of around $20 million from the offering.

U.S. HOT STOCKS FUTURES: HOT STOCKS TO WATCH

U.S. HOT STOCKS FUTURES: HOT STOCKS TO WATCH

Cyclacel Agrees to Sell Patents to Celgene; Litigation to Be Dismissed

5 of Last Week's Biggest Losers

These five stocks bucked last week's uptrend by taking a dive.

The Best of 2012 #7: Sunesis

After announcing an expansion of P3 trials for its acute myeloid leukemia drug, Sunesis Pharmaceuticals shot to new heights, up 325% for the year. That puts it at #7 on our list of the very best stocks in healthcare for 2012.

5 of Last Week's Biggest Winners

These five stocks soared over the past few days.

Cyclacel Pharma May Bring Huge Returns For The Long Term

4 Biotechs' Dominant Moves

A closer look at today's big market movers

Why These 3 Biotech Stocks Are Winning

Gilead, Amarin, and Cyclacel are all up over 5%

See More CYCC News...

Sector

Healthcare

Industry

Drugs

CYCLACEL PHARMACEUTICALS, INC. (CYCC) Description

A development-stage biopharmaceutical company dedicated to the discovery, development and eventual commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Website: http://www.cyclacel.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks